피부과 영상 진단 기기 시장 : 규모, 점유율 및 동향 분석 보고서 - 모달리티별, 용도별, 최종 용도별, 지역별 부문 예측(2025-2030년)

Market Size & Trends:

The global diagnostic dermatology imaging devices market size was estimated at USD 4.93 billion in 2024 and is projected to grow at a CAGR of 9.4% from 2025 to 2030. The growing prevalence of skin disorders, rising awareness about skin cancers, and the growing demand for non-invasive diagnostic procedures are the factors affecting the market's growth. There is a significant rise in the number of skin cancer cases globally, which drives the need for advanced solutions to facilitate better cancer care. For instance, in February 2025, Canfield Scientific introduced the new D2 Digital Dermatoscope, which has a high-resolution display, and its design enhances ease of use and elevates the user experience. It enables consistent, standardized imaging for accurate documentation and precise diagnostics.

The increasing prevalence of skin disorders and skin cancers significantly drives the growth of the diagnostic dermatology imaging devices market. Skin cancer, including melanoma and non-melanoma types such as basal cell carcinoma and squamous cell carcinoma, continues to rise globally due to factors like prolonged UV exposure, aging populations, and enhanced awareness and screening efforts. According to the American Academy of Dermatology, skin cancer is most prevalent in the U.S.; approximately 9,500 people are diagnosed with skin cancer daily, and over 1 million individuals are currently suffering from melanoma.

Furthermore, the Global Cancer Observatory (GLOBOCAN) reports that the number of skin melanoma cases is expected to increase to 599,565. Skin cancers are predominantly found in women under the age of 50, but they occur significantly more frequently in men over the age of 50. This discrepancy can be attributed to differences in recreational and occupational UV exposure. Estimates suggest that around 1 in 27 men and 1 in 40 women are expected to suffer from melanoma.

The growing awareness of early disease diagnosis has emerged as a critical driver in healthcare, particularly in fields like dermatology, where early intervention can significantly improve patient outcomes. Increased public education, widespread use of digital health platforms, and a greater understanding of skin cancer risks empowered individuals to seek medical attention sooner, creating a demand for accurate, non-invasive diagnostic tools. This trend is particularly significant for detecting conditions such as melanoma, where early identification can be lifesaving. Consequently, dermatology clinics, hospitals, and even primary care providers increasingly adopt advanced imaging technologies to address the market demand.

This directly influences technological innovation and strategic activity within the companies operating in this market. For instance, in May 2023, Orlucent, Inc. received FDA Breakthrough Device Designation for its Skin Fluorescence Imaging System, which provides a non-invasive molecular analysis of moles. This approval marks a significant advancement in the market for diagnostic dermatology imaging devices. The handheld, non-invasive device uses a topically applied fluorescent peptide to detect avB3 integrin, which indicates early melanoma development. By offering molecular-level imaging and analysis of moles, the mSFI system allows clinicians to evaluate the biological tissue remodeling activity associated with atypical moles, thereby enabling the early detection of melanoma without requiring invasive procedures.

Additionally, the growing demand for non-invasive diagnostic approaches is fueling market expansion. Both patients and clinicians increasingly favor methods that eliminate the risks, discomfort, and downtime linked with conventional biopsies. This trend is particularly prominent in dermatology-especially skin cancer diagnosis-where early detection is vital. Techniques like optical coherence tomography (OCT), reflectance confocal microscopy (RCM), and dermoscopy deliver detailed skin lesion imaging, supporting accurate assessment and ongoing monitoring.

Technological advancements have played a pivotal role in this transition. Devices like DermaSensor, which received FDA clearance in January 2024, utilize AI-powered spectroscopy to non-invasively assess skin lesions for potential malignancy. In clinical studies, DermaSensor demonstrated a sensitivity of 97% in detecting various skin cancers, including melanoma, basal cell carcinoma, and squamous cell carcinoma. Such innovations not only improve diagnostic accuracy but also reduce reliance on subjective clinical assessments, enabling more consistent and efficient evaluations. The further emergence of technologically advanced devices, such as hyperspectral dermatoscopes, offers a promising approach for non-invasive skin evaluation. These devices capture a broad range of wavelengths with high precision, identifying and characterizing various skin conditions. Preliminary results suggest that hyperspectral imaging can enhance diagnostic accuracy, providing a new platform for research and clinical applications in dermatology.

Global Diagnostic Dermatology Imaging Devices Market Report Segmentation

This report forecasts country-level revenue growth at global, regional, and country level and analyzes the latest industry trends and opportunities in each sub-segment from 2018 to 2030. For this study, Grand View Research has segmented the global diagnostic dermatology imaging devices market report based on the modality, application, end use, and region:

• Modality Outlook (Revenue, USD Million, 2018 - 2030)
• Advanced Diagnostic Imaging Devices
  • Optical Coherence Tomography (OCT) Devices
  • Reflectance Confocal Microscopy (RCM) Devices
  • High-frequency Ultrasound Devices
  • Others
• Surface Visualization Devices
  • Dermatoscopes
  • Photographic Imaging Systems
  • Others
• Biopsy Devices
• Molecular Diagnostic Devices & Platforms
• Application Outlook (Revenue, USD Million 2018 - 2030)
• Skin Cancer
  • Melanoma
  • Non-melanoma
• Inflammatory & Autoimmune Skin Diseases
  • Psoriasis
  • Eczema/Atopic Dermatitis
  • Others
• Infectious Skin Conditions
• Wound & Ulcer Assessment
• End Use Outlook (Revenue, USD Million 2018 - 2030)
• Hospitals
• Dermatology Clinics/Centers
• Cancer Centers/Oncology Clinics
• Others
• Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Modality
  • 1.2.2. Application
  • 1.2.3. End-use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Modality outlook
  • 2.2.2. Application & end-use outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Diagnostic Dermatology Imaging Devices Market Variables, Trends & Scope

• 3.1. Market Dynamics
  • 3.1.1. Market Driver Analysis
    • 3.1.1.1. Increasing prevalence of skin disorders and skin cancers
    • 3.1.1.2. Growing awareness of early disease diagnosis
    • 3.1.1.3. Rising demand for non-invasive diagnostic procedures
  • 3.1.2. Market Restraint Analysis
    • 3.1.2.1. Lack of skilled professionals and regulatory challenges
    • 3.1.2.2. High costs of dermatology imaging devices
  • 3.1.3. Market Opportunity Analysis
    • 3.1.3.1. Increasing Demand for portable and handheld imaging devices
    • 3.1.3.2. Emerging market opportunities in developing and low-income countries
• 3.2. Diagnostic Dermatology Imaging Devices Market Analysis Tools
  • 3.2.1. Industry Analysis - Porter's
    • 3.2.1.1. Bargaining power of suppliers
    • 3.2.1.2. Bargaining power of buyers
    • 3.2.1.3. Threat of substitutes
    • 3.2.1.4. Threat of new entrants
    • 3.2.1.5. Competitive rivalry
  • 3.2.2. PESTEL Analysis
    • 3.2.2.1. Political landscape
    • 3.2.2.2. Economic landscape
    • 3.2.2.3. Social landscape
    • 3.2.2.4. Technological landscape
    • 3.2.2.5. Environmental landscape
    • 3.2.2.6. Legal landscape

Chapter 4. Diagnostic Dermatology Imaging Devices Market: Modality Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Diagnostic Dermatology Imaging Devices Market: Modality Movement Analysis
• 4.3. Diagnostic Dermatology Imaging Devices Market by Modality Outlook (Revenue, USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Advanced Diagnostic Imaging Systems
  • 4.5.1. Advanced Diagnostic Imaging Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 4.5.1.1. Optical Coherence Tomography (OCT) Devices
      • 4.5.1.1.1. Optical Coherence Tomography (OCT) Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 4.5.1.2. Reflectance Confocal Microscopy (RCM) Devices
      • 4.5.1.2.1. Reflectance Confocal Microscopy (RCM) Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 4.5.1.3. High-frequency Ultrasound Devices
      • 4.5.1.3.1. High-frequency Ultrasound Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 4.5.1.4. Others
      • 4.5.1.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 4.6. Surface Visualization Devices
  • 4.6.1. Surface Visualization Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 4.6.1.1. Dermatoscopes
      • 4.6.1.1.1. Dermatoscopes Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 4.6.1.2. Photographic Imaging Systems
      • 4.6.1.2.1. Photographic Imaging Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 4.6.1.3. Others
      • 4.6.1.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 4.7. Biopsy Devices
  • 4.7.1. Biopsy Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 4.8. Molecular Diagnostic Devices & Platforms
  • 4.8.1. Molecular Diagnostic Devices & Platforms Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 5. Diagnostic Dermatology Imaging Devices Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Diagnostic Dermatology Imaging Devices Market: Application Movement Analysis
• 5.3. Diagnostic Dermatology Imaging Devices Market by Application Outlook (Revenue, USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Skin Cancer
  • 5.5.1. Skin Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.1.1. Melanoma
      • 5.5.1.1.1. Melanoma Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.1.2. Non-melanoma
      • 5.5.1.2.1. Non-melanoma Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 5.6. Inflammatory & Autoimmune Skin Diseases
  • 5.6.1. Inflammatory & Autoimmune Skin Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.1.1. Psoriasis
      • 5.6.1.1.1. Psoriasis Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.1.2. Eczema/Atopic Dermatitis
      • 5.6.1.2.1. Eczema/Atopic Dermatitis Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.1.3. Others
      • 5.6.1.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 5.7. Infectious Skin Conditions
  • 5.7.1. Infectious Skin Conditions Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 5.8. Wound & Ulcer Assessment
  • 5.8.1. Wound & Ulcer Assessment Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Diagnostic Dermatology Imaging Devices Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Diagnostic Dermatology Imaging Devices Market: End use Movement Analysis
• 6.3. Diagnostic Dermatology Imaging Devices Market by End use Outlook (Revenue, USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Hospitals
  • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 6.6. Dermatology Clinics/Centers
  • 6.6.1. Dermatology Clinics/Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 6.7. Cancer Centers/Oncology Clinics
  • 6.7.1. Cancer Centers/Oncology Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 6.8. Others
  • 6.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Diagnostic Dermatology Imaging Devices Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Regional Diagnostic Dermatology Imaging Devices Market Movement Analysis
• 7.3. Diagnostic Dermatology Imaging Devices Market: Regional Estimates & Trend Analysis by Modality
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. North America
  • 7.5.1. North America Diagnostic Dermatology Imaging Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. U.S. Diagnostic Dermatology Imaging Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. Canada Diagnostic Dermatology Imaging Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. Reimbursement scenario
    • 7.5.4.5. Mexico Diagnostic Dermatology Imaging Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 7.6. Europe
  • 7.6.1. Europe Diagnostic Dermatology Imaging Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6.2. UK
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. UK Diagnostic Dermatology Imaging Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6.3. Germany
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. Germany Diagnostic Dermatology Imaging Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6.4. France
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. Reimbursement scenario
    • 7.6.4.5. France Diagnostic Dermatology Imaging Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6.5. Italy
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Reimbursement scenario
    • 7.6.5.5. Italy Diagnostic Dermatology Imaging Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6.6. Spain
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. Reimbursement scenario
    • 7.6.6.5. Spain Diagnostic Dermatology Imaging Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6.7. Denmark
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. Reimbursement scenario
    • 7.6.7.5. Denmark Diagnostic Dermatology Imaging Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6.8. Sweden
    • 7.6.8.1. Key Country Dynamics
    • 7.6.8.2. Competitive Scenario
    • 7.6.8.3. Regulatory Framework
    • 7.6.8.4. Reimbursement scenario
    • 7.6.8.5. Sweden Diagnostic Dermatology Imaging Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6.9. Norway
    • 7.6.9.1. Key Country Dynamics
    • 7.6.9.2. Competitive Scenario
    • 7.6.9.3. Regulatory Framework
    • 7.6.9.4. Reimbursement scenario
    • 7.6.9.5. Norway Diagnostic Dermatology Imaging Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Asia Pacific Diagnostic Dermatology Imaging Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7.2. Japan
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. Japan Diagnostic Dermatology Imaging Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7.3. China
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. China Diagnostic Dermatology Imaging Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7.4. India
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Regulatory Framework
    • 7.7.4.4. Reimbursement scenario
    • 7.7.4.5. India Diagnostic Dermatology Imaging Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Competitive Scenario
    • 7.7.5.3. Regulatory Framework
    • 7.7.5.4. Reimbursement scenario
    • 7.7.5.5. South Korea Diagnostic Dermatology Imaging Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7.6. Australia
    • 7.7.6.1. Key Country Dynamics
    • 7.7.6.2. Competitive Scenario
    • 7.7.6.3. Regulatory Framework
    • 7.7.6.4. Reimbursement scenario
    • 7.7.6.5. Australia Diagnostic Dermatology Imaging Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7.7. Thailand
    • 7.7.7.1. Key Country Dynamics
    • 7.7.7.2. Competitive Scenario
    • 7.7.7.3. Regulatory Framework
    • 7.7.7.4. Reimbursement scenario
    • 7.7.7.5. Thailand Diagnostic Dermatology Imaging Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 7.8. Latin America
  • 7.8.1. Latin America Diagnostic Dermatology Imaging Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.8.2. Brazil
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. Reimbursement scenario
    • 7.8.2.5. Brazil Diagnostic Dermatology Imaging Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.8.3. Argentina
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. Reimbursement scenario
    • 7.8.3.5. Argentina Diagnostic Dermatology Imaging Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 7.9. Middle East & Africa
  • 7.9.1. Middle East & Africa Diagnostic Dermatology Imaging Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.9.2. South Africa
    • 7.9.2.1. Key Country Dynamics
    • 7.9.2.2. Competitive Scenario
    • 7.9.2.3. Regulatory Framework
    • 7.9.2.4. Reimbursement scenario
    • 7.9.2.5. South Africa Diagnostic Dermatology Imaging Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.9.3. Saudi Arabia
    • 7.9.3.1. Key Country Dynamics
    • 7.9.3.2. Competitive Scenario
    • 7.9.3.3. Regulatory Framework
    • 7.9.3.4. Reimbursement scenario
    • 7.9.3.5. Saudi Arabia Diagnostic Dermatology Imaging Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.9.4. UAE
    • 7.9.4.1. Key Country Dynamics
    • 7.9.4.2. Competitive Scenario
    • 7.9.4.3. Regulatory Framework
    • 7.9.4.4. Reimbursement scenario
    • 7.9.4.5. UAE Diagnostic Dermatology Imaging Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.9.5. Kuwait
    • 7.9.5.1. Key Country Dynamics
    • 7.9.5.2. Competitive Scenario
    • 7.9.5.3. Regulatory Framework
    • 7.9.5.4. Reimbursement scenario
    • 7.9.5.5. Kuwait Diagnostic Dermatology Imaging Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. Canfield Scientific
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. Caliber Imaging & Diagnostics
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Michelson Diagnostics (MDL)
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. SciBase AB
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. DermaSensor Inc.
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Damae Medical
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. Apollo Medical Optics
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Enspectra Health, Inc.
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Cortex Technology
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Dermavision Solutions
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives
  • 8.2.11. Pixience
    • 8.2.11.1. Company overview
    • 8.2.11.2. Financial performance
    • 8.2.11.3. Product benchmarking
    • 8.2.11.4. Strategic initiatives
  • 8.2.12. Adamo srl. (Horus)
    • 8.2.12.1. Company overview
    • 8.2.12.2. Financial performance
    • 8.2.12.3. Product benchmarking
    • 8.2.12.4. Strategic initiatives
  • 8.2.13. Dermus Ltd.
    • 8.2.13.1. Company overview
    • 8.2.13.2. Financial performance
    • 8.2.13.3. Product benchmarking
    • 8.2.13.4. Strategic initiatives